PracticeUpdate Oncology February 2019

5

PRACTICEUPDATE BENIGN HEMATOLOGY BOARD Editor-in-Chief Michael H. Kroll MD

Associate Editors

Editorial Contributors

Rakhi Naik MD MHS Associate Director for Hematology,

Kelly N. Casteel MD Fellow in Hematology/Oncology, MD Anderson Cancer Center, Houston, Texas

Professor of Medicine, Chief of the Section of Benign Hematology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Hematology/Oncology Fellowship Program; Assistant Professor of Medicine, Hematology, Johns Hopkins Medicine, Baltimore, Maryland Cristhiam M. Rojas Hernandez MD Assistant Professor of Hematology, MD Anderson Cancer Center, Houston, Texas

Eric Fountain MD, MA Fellow in Hematology/Oncology, MD Anderson Cancer Center, Houston, Texas

PRACTICEUPDATE ONCOLOGY | CENTERS OF EXCELLENCE Our centers of excellence in the treatment of advanced prostate cancer, brain cancer, metastatic breast cancer and renal cell carcinoma leverage technology to create a collaborative and comprehensive way to improve patient care. These unique centers have the key advantage of a real world academic center as well as the features and enhancements that only PracticeUpdate and Elsevier can provide to foster an expert-led team approach that helps you stay ahead.

ADVANCED PROSTATE CANCER Editors-in-Chief Thomas J. Guzzo MD, MPH

Associate Editors

Brian E. Lewis MD, MPH Assistant Professor of Clinical Medicine, Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, Louisiana

Jonathan Silberstein MD, MBA Candidate 2018 Assistant Professor of Urology; Chief, Section of Urologic Oncology, Department of Urology, Tulane University School of Medicine; Chief of Urology Service, Department of Surgery, Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana

Chief of Urology, Associate Program Director, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania Oliver A. Sartor MD Laborde Professor, Cancer Research, Medicine and Urology Departments, Tulane School of Medicine, New Orleans, Louisiana

BRAIN CANCER Editors-in-Chief

Associate Editor

Minesh P. Mehta MD, FASTRO Deputy Director, Chief of Radiation Oncology, Miami Cancer Institute, Miami, Florida

Patrick Y. Wen MD Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute; Director, Division of Cancer Neurology, Department of Neurology, Brigham and Women’s Hospital; Professor of Neurology, Harvard Medical School, Boston, Massachusetts

Manmeet Ahluwalia MD, FACP Dean and Diane Miller Family Endowed Chair in Neuro-Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute and Taussig Cancer Institute, Cleveland Clinic; Associate Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio

METASTATIC BREAST CANCER Editor-in-Chief

Associate Editors

Lee Schwartzberg MD, FACP Executive Director, West Cancer Center; Professor of Medicine and Division Chief of Hematology/Oncology, The University of Tennessee Health Science Center, Tennessee

Reshma L. Mahtani DO Associate Professor, Division of Hematology/Oncology, Sylvester

Lillie D. Shockney RN, BS, MAS University Distinguished Service Professor of Breast Cancer, Administrative Director, Johns Hopkins Breast Center and Cancer Survivorship Programs, Baltimore, Maryland

Comprehensive Cancer Center, University of Miami Health System, Miami, Florida

RENAL CELL CARCINOMA Editors-in-Chief Sumanta K. Pal MD

Associate Editor

Advisory Board

Eric Jonasch MD Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine; Director, VHL Clinical Center, The University of Texas MD Anderson Cancer Center, Houston, Texas Oliver A. Sartor MD Laborde Professor, Cancer Research, Medicine and Urology Departments, Tulane School of Medicine, New Orleans, Louisiana

Heather R. Greene MSN, FNP, AOCNP Nurse Practitioner, The West Clinic, Memphis, Tennessee

Associate Professor, Department of Medical Oncology & Therapeutics Research; Co-Director, Kidney Cancer Program, City of Hope, Duarte, California Bradley G. Somer MD Medical Oncologist; Associate Professor of Hematology/Oncology, University of Tennessee Health Science Center; and Senior Partner, West Cancer Center, Memphis, Tennessee

VOL. 3 • NO. 1 • 2019